Medline orders correction of convenience kits containing lidocaine and bupivacaine in dextrose injection

Medline has issued a correction for certain convenience kits that include lidocaine hydrochloride and bupivacaine hydrochloride mixed with dextrose injection.

The FDA has classified this recall as the most serious type, warning that continued use of the kits without correction could cause serious injury or death.

In a letter sent on May 6, Medline instructed customers to immediately check their inventory for the affected lot numbers, quarantine the kits, and complete a recall response form to obtain over-labels that guide staff to remove and discard the drug components before using the kits.

All other components in the kits may still be used, and any parties who have redistributed the kits should be notified of the recall.